Which Vaccines Protect Against Hepatitis B? 

Vaccination is the primary method used to prevent Hepatitis B, a viral infection that causes liver inflammation and can lead to serious long-term health complications. In the United Kingdom, the Hepatitis B vaccine is highly effective and safe, working by stimulating the immune system to produce antibodies that recognise and neutralise the virus upon exposure. Since 2017, the vaccine has been integrated into the universal childhood immunisation schedule, ensuring that infants are protected from an early age. For adults and older children not covered by this programme, the vaccine is targeted at those with specific lifestyle, occupational, or clinical risks to ensure comprehensive protection across the population. 

What We’ll Discuss in This Article 

• The types of Hepatitis B vaccines currently used in the UK. 

• The 6 in 1 vaccine used for infant immunisation. 

• Dosing schedules for adults and high-risk groups. 

• Combined vaccine options for Hepatitis A and B protection. 

• Eligibility for receiving the vaccine on the NHS. 

• Safety, side effects, and the duration of vaccine protection. 

The 6 in 1 Vaccine for Infants 

In the UK, infants are protected against Hepatitis B through a combined injection known as the 6 in 1 vaccine. This vaccine is a core part of the routine childhood immunisation programme and protects against six serious diseases: diphtheria, hepatitis B, hib (Haemophilus influenzae type b), polio, tetanus, and whooping cough. The NHS provides the 6 in 1 vaccine to all babies at 8, 12, and 16 weeks of age to ensure they develop early and robust immunity. 

By including Hepatitis B in this routine schedule, the UK aims to eliminate the domestic transmission of the virus over time. The vaccine used in this programme is inactivated, meaning it does not contain a live virus and cannot cause any of the diseases it protects against. Babies born to mothers with Hepatitis B receive additional doses of a standalone Hepatitis B vaccine at birth and at four weeks of age to provide immediate protection against mother to child transmission. 

Standalone and Combined Vaccines for Adults 

For adults and older children who are not part of the infant programme, Hepatitis B protection is usually delivered via a standalone (monovalent) vaccine. This version is used for individuals who require protection specifically against this virus due to their work, health status, or travel plans. In certain clinical circumstances, a combined vaccine that protects against both Hepatitis A and Hepatitis B may be used, particularly for travellers or individuals with chronic liver disease who require broad protection. 

Vaccine Type	Target Population	Dosing Schedule
6-in-1 (Infanrix hexa / Vaxelis)	Infants	3 doses (8, 12, 16 weeks)
Standalone (Engerix B / HBvaxPRO)	High-risk adults/children	3 doses over 6 months
Combined (Twinrix)	High-risk / Travellers	3 doses over 6 months

The standalone vaccine is highly effective, with the majority of healthy adults developing full immunity after completing the three dose course. The choice between a standalone or combined product is made by a healthcare professional based on a thorough assessment of the individual’s specific risk factors and previous vaccination history. 

Dosing Schedules and Rapid Protection 

The standard vaccination schedule for adults and children at risk consists of three doses administered over a six month period. Typically, the second dose is given one month after the first, and the third dose is given five months after the second. This schedule is designed to provide long lasting, likely lifelong, protection by allowing the immune system to build a memory of the viral surface antigen. 

In situations where protection is needed more urgently, such as following a potential exposure or for last minute travel, an accelerated schedule may be used. This can involve doses being given at zero, one, and two months, or even a very rapid schedule with doses at zero, seven, and twenty one days. NICE clinical guidelines state that where an accelerated schedule is used, a fourth booster dose is often recommended twelve months later to ensure the immunity is maintained over the long-term. 

Eligibility for NHS Vaccination 

While the infant vaccine is universal, adult Hepatitis B vaccination on the NHS is targeted at groups with an increased risk of infection. This includes people whose work may expose them to blood or bodily fluids, such as healthcare workers, laboratory staff, and members of the emergency services. Individuals with chronic liver or kidney disease are also eligible, as they are more vulnerable to severe outcomes if they contract the virus. 

Other eligible high-risk groups include: 

• People who inject drugs or live with someone who does. 

• Men who have sex with men. 

• People who change sexual partners frequently. 

• Household contacts of a person known to have chronic Hepatitis B. 

• Travellers to regions where Hepatitis B is common. 

• Foster carers and people living in residential care for those with learning disabilities. 

The UK Health Security Agency provides specific guidance on the immunisation of these groups to prevent outbreaks and protect vulnerable individuals. 

Vaccine Safety and Common Side Effects 

The Hepatitis B vaccine has an excellent safety record and has been used globally for several decades. Because it is an inactivated vaccine, it cannot cause a Hepatitis B infection. Most people experience only very mild side effects that resolve within a day or two. The most common reaction is temporary soreness, redness, or a small lump at the injection site. 

Some individuals may experience mild systemic symptoms such as a slight fever, fatigue, or a headache. Serious allergic reactions are extremely rare. Healthcare providers will always ask about previous allergies to vaccine components, such as yeast, before administering the injection. For the majority of the population, the benefits of preventing a lifelong liver infection far outweigh the risk of minor, short term side effects. 

Duration of Protection and Testing 

Once the full course of vaccination is completed, most people do not require further boosters, as the immune system retains a long-term memory of the virus. In certain high-risk occupations, such as healthcare, a blood test may be performed five years after the initial course to check the level of antibodies (anti HBs) in the blood. If the levels have dropped significantly, a single booster dose may be recommended. 

It is important to note that the vaccine only protects against the Hepatitis B virus and does not offer protection against other types of hepatitis, such as A or C. For those who completed the vaccination many years ago, the protection is generally considered to be lifelong in healthy individuals. If a person is immunocompromised, their clinical team may recommend more frequent testing and booster doses to ensure they remain protected. 

Conclusion 

Hepatitis B is prevented in the UK through the routine 6 in 1 infant vaccine and targeted standalone or combined vaccines for high-risk adults. These vaccines provide a safe and highly effective way to build long-term immunity against liver infection and its complications. Ensuring that both routine infant doses and necessary adult high-risk courses are completed is the most effective way to protect personal and public health. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T) 

This article provides medically factual health information regarding Hepatitis B vaccines, strictly aligned with NHS and NICE clinical guidelines. The content is developed by a medical writing team and reviewed by Dr. Rebecca Fernandez, a UK-trained physician with experience in internal medicine, surgery, and emergency care. All information follows current UK public health protocols to ensure patient safety and clinical accuracy.